The Valley Desk

NCT04198766 · Interventional trial

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Gastric Cancer, Head and Neck Cancer, Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Resectable Non-Small-Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov